Document 0200
 DOCN  M9650200
 TI    Testing of saliva and serum for HIV in high-risk populations. Ad Hoc
       Group for the Comparative Saliva and Serum Study.
 DT    9605
 AU    Vall Mayans M; Casabona J; Rabella N; De Miniac D; AIDS Programme,
       Department of Health, Generalitat de Catalunya,; Barcelona, Spain.
 SO    Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):710-3. Unique Identifier
       : AIDSLINE MED/96089508
 AB    Paired samples of saliva and serum from 286 high-risk subjects were
       tested for HIV using two commercial enzyme immunoassays following the
       same WHO testing strategy supplemented with a Western blot technique.
       Agreement between HIV testing in both sample types was 98.9% (95%
       confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme
       GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7%
       (151/153). These results support previous data showing that in some
       situations saliva might be an effective alternative to serum for HIV
       testing.
 DE    Adult  AIDS Serodiagnosis/*METHODS  Blotting, Western  Confidence
       Intervals  Female  Human  HIV Antibodies/*ANALYSIS  HIV
       Infections/*DIAGNOSIS  HIV Seroprevalence  Immunoenzyme Techniques  Male
       Saliva/*VIROLOGY  Sensitivity and Specificity  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).